Generic for revlimid

Revlimid is the brand, lenalidomide is the generic. No difference/ the patent is expiring for Revlimid soon everything will be lenalidomide.

In 2024, a generic version of Revlimid was approved by the Food and Drug Administration (FDA). In terms of safety, quality, performance characteristics, and intended use, generic Revlimid is the same as the marketed brand-name drug. Generic Revlimid can be used as a substitute for Revlimid.

Revlimid is available in generic form. What Are Side Effects of Revlimid? Revlimid may cause serious side effects including: hives,; difficulty breathing

Revlimid 2,5 mg tvrd tobolky . Revlimid 5 mg tvrd tobolky Revlimid 7,5 mg tvrd tobolky Revlimid 10 mg tvrd tobolky . Revlimid 15 mg tvrd tobolky . Revlimid 20 mg tvrd tobolky . Revlimid 25 mg tvrd tobolky . lenalidomidum . Tento př pravek podl h dalš mu sledov n . To umožn rychl z sk n nov ch informac o

Revlimid 5 mg Hartkapseln . Revlimid 7,5 mg Hartkapseln . Revlimid 10 mg Hartkapseln . Revlimid 15 mg Hartkapseln . Revlimid 20 mg Hartkapseln . Revlimid 25 mg Hartkapseln . 2. QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG . Revlimid 2,5 mg Hartkapseln Jede Kapsel enth lt 2,5 mg Lenalidomid. Sonstige(r) Bestandteil(e) mit bekannter Wirkung Jede

lenalidomide capsules (the generic equivalent of Revlimid) in the Mydayis. October. $ 113. Pitavastatin Tablets

Revlimid and generic lenalidomide are both approved for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes

The generic ingredient in REVLIMID is lenalidomide. There are fourteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the lenalidomide profile page. DrugPatentWatch Litigation and Generic Entry Outlook for Revlimid. A generic version of Revlimid was approved as

Revlimid generics launched in Europe by STADA and Sandoz.